Patent · US Active

Chemical compositions and methods of use

US12366575B2 · kind B2 · utility

0Cited by
2References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2021
Grant dateJul 22, 2025
Priority date
Expiry dateAug 10, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7028
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention is directed to methods for detecting a plasma cell dyscrasia like myeloma or MGUS, methods for determining whether a plasma cell dyscrasiais stable or progressive, methods for determining a risk for disease relapse, and methods for determining a response by a subject having a plasma cell dyscrasia to a therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.